NO20044250L - Heterocykliske amid-derivativer for behandling av diabetes og andre sykdommer - Google Patents
Heterocykliske amid-derivativer for behandling av diabetes og andre sykdommerInfo
- Publication number
- NO20044250L NO20044250L NO20044250A NO20044250A NO20044250L NO 20044250 L NO20044250 L NO 20044250L NO 20044250 A NO20044250 A NO 20044250A NO 20044250 A NO20044250 A NO 20044250A NO 20044250 L NO20044250 L NO 20044250L
- Authority
- NO
- Norway
- Prior art keywords
- diabetes
- diseases
- treatment
- amide derivatives
- heterocyclic amide
- Prior art date
Links
- -1 Heterocyclic amide Chemical class 0.000 title 1
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36270202P | 2002-03-08 | 2002-03-08 | |
PCT/US2003/006784 WO2003075924A1 (fr) | 2002-03-08 | 2003-03-07 | Derives d'amide heterocyclique destines au traitement du diabete et d'autres maladies |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20044250L true NO20044250L (no) | 2004-11-03 |
Family
ID=27805215
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20044250A NO20044250L (no) | 2002-03-08 | 2004-10-07 | Heterocykliske amid-derivativer for behandling av diabetes og andre sykdommer |
Country Status (14)
Country | Link |
---|---|
US (2) | US7102000B2 (fr) |
EP (1) | EP1487443A4 (fr) |
JP (1) | JP2005530705A (fr) |
KR (1) | KR20050006126A (fr) |
CN (1) | CN1649586A (fr) |
AU (1) | AU2003225682A1 (fr) |
CA (1) | CA2478342A1 (fr) |
IL (1) | IL163952A0 (fr) |
MX (1) | MXPA04008733A (fr) |
NO (1) | NO20044250L (fr) |
RU (1) | RU2004129752A (fr) |
TW (1) | TW200306184A (fr) |
WO (1) | WO2003075924A1 (fr) |
ZA (1) | ZA200408057B (fr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0203367A3 (en) | 1999-08-31 | 2004-12-28 | Maxia Pharmaceuticals Inc San | Benzylidine-thiazolidinediones and analogues and their use in the treatment of diabetes |
EP1385465A4 (fr) * | 2001-03-07 | 2005-09-07 | Incyte San Diego Inc | Derives heterocycliques pour le traitement du cancer et d'autres maladies proliferatives |
EP1377559A4 (fr) * | 2001-03-08 | 2005-09-28 | Incyte San Diego Inc | Molecules activant un recepteur rxr |
WO2003016267A1 (fr) * | 2001-08-17 | 2003-02-27 | Incyte San Diego Incorporated | Derives d'oxime pour le traitement de la dyslipidemie et de l'hypercholesterolemie |
US7196108B2 (en) * | 2002-03-08 | 2007-03-27 | Incyte San Diego Inc. | Bicyclic heterocycles for the treatment of diabetes and other diseases |
US7102000B2 (en) * | 2002-03-08 | 2006-09-05 | Incyte San Diego Inc. | Heterocyclic amide derivatives for the treatment of diabetes and other diseases |
ZA200509355B (en) * | 2003-04-18 | 2007-03-28 | Incyte San Diego Inc | Substituted isochroman compounds for the treatment of metabolic disorders, cancer and other diseases |
EP1566202A1 (fr) * | 2004-02-23 | 2005-08-24 | Sahltech I Göteborg AB | Utilisation d'agonistes de la resistine pour le traitement de l'arthrite rheumatoide |
US7122700B2 (en) | 2004-07-30 | 2006-10-17 | Xerox Corporation | Arylamine processes |
GT200500185A (es) * | 2004-08-09 | 2006-04-10 | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos | |
WO2006025551A1 (fr) * | 2004-08-30 | 2006-03-09 | Takeda Pharmaceutical Company Limited | Méthode de criblage |
JP2009512637A (ja) | 2005-09-30 | 2009-03-26 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 異常脂血症、高コレステロール血症及び糖尿病の処置のためのrxrアゴニストとしてのジヒドロ−[1h]−キノリン−2−オン誘導体 |
MX2010012626A (es) * | 2008-05-20 | 2011-02-22 | Merck Sharp & Dohme | Produccion eficiente de proteinas heterologas utilizando inhibidores de manosil transferasa. |
WO2012153775A1 (fr) | 2011-05-10 | 2012-11-15 | 国立大学法人神戸大学 | Dérivé de thioxothiazolidine ayant un effet inhibiteur sur la fonction ras |
WO2015066647A2 (fr) | 2013-11-03 | 2015-05-07 | The Regents Of The University Of California | Liquides ioniques pour administration transdermique de médicaments |
JP6632720B2 (ja) * | 2016-06-07 | 2020-01-22 | 三菱電機株式会社 | 温度推定方法 |
CA3035414C (fr) | 2016-08-29 | 2022-02-22 | The Regents Of The University Of California | Formulations topiques a base d'especes ioniques pour le traitement de la peau |
US10828265B2 (en) | 2016-12-09 | 2020-11-10 | The Regents Of The University Of California | Formulations of propranolol and analogs as an amorphous melt or ionic liquid for transdermal drug delivery |
Family Cites Families (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4051842A (en) | 1975-09-15 | 1977-10-04 | International Medical Corporation | Electrode and interfacing pad for electrical physiological systems |
DE2626348C3 (de) | 1976-06-11 | 1980-01-31 | Siemens Ag, 1000 Berlin Und 8000 Muenchen | Implantierbare Dosiereinrichtung |
JPS5538359A (en) | 1978-09-12 | 1980-03-17 | Hamari Yakuhin Kogyo Kk | Preparation of 2-(3-benzoylphenyl)-propionic acid |
US4383529A (en) | 1980-11-03 | 1983-05-17 | Wescor, Inc. | Iontophoretic electrode device, method and gel insert |
IL72684A (en) | 1984-08-14 | 1989-02-28 | Israel State | Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs |
US4931279A (en) | 1985-08-16 | 1990-06-05 | Bausch & Lomb Incorporated | Sustained release formulation containing an ion-exchange resin |
US4668506A (en) | 1985-08-16 | 1987-05-26 | Bausch & Lomb Incorporated | Sustained-release formulation containing and amino acid polymer |
US4713244A (en) | 1985-08-16 | 1987-12-15 | Bausch & Lomb Incorporated | Sustained-release formulation containing an amino acid polymer with a lower alkyl (C1 -C4) polar solvent |
CA1325222C (fr) | 1985-08-23 | 1993-12-14 | Lederle (Japan), Ltd. | Procede pour la production d'acide 4-biphenylylacetique |
EP0304493B1 (fr) | 1987-03-11 | 1992-09-02 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Derives d'hydroxystyrene |
FI91869C (fi) * | 1987-03-18 | 1994-08-25 | Tanabe Seiyaku Co | Menetelmä antidiabeettisena aineena käytettävien bensoksatsolijohdannaisten valmistamiseksi |
JPS63230689A (ja) * | 1987-03-18 | 1988-09-27 | Tanabe Seiyaku Co Ltd | ベンゾオキサジン誘導体 |
US5330998A (en) | 1988-03-08 | 1994-07-19 | Pfizer Inc. | Thiazolidinedione derivatives as hypoglycemic agents |
US5223522A (en) | 1988-03-08 | 1993-06-29 | Pfizer Inc. | Thiazolidinedione hypoglycemic agents |
IE940525L (en) | 1988-05-25 | 1989-11-25 | Warner Lambert Co | Known and selected novel arylmethylenyl derivatives of¹thiazolidinones, imidazolidinones and oxazolidinones useful¹as antiallergy agents and antiinflammatory agents |
DE69227689T2 (de) | 1991-07-22 | 1999-04-22 | Pfizer | Verfahren zur herstellung von (s)-4-[3-(5-methyl-2-phenyl-4-oxazolyl)- 1-hydroxypropyl] brombenzol |
ATE256653T1 (de) | 1992-04-22 | 2004-01-15 | Ligand Pharm Inc | Verbindungen mit retinoid x receptorselektivität |
US5780676A (en) | 1992-04-22 | 1998-07-14 | Ligand Pharmaceuticals Incorporated | Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors |
ZA936492B (en) | 1992-09-10 | 1995-03-02 | Lilly Co Eli | Compounds useful as hypoglycemic agents and for treating Alzheimer's disease. |
JPH08506323A (ja) | 1992-11-25 | 1996-07-09 | ラ ホヤ キャンサー リサーチ ファウンデーション | Rxrホモダイマー形成ならびに架橋二環式芳香族化合物および調節遺伝子発現におけるそれらの使用 |
DE4317320A1 (de) | 1993-05-25 | 1994-12-01 | Boehringer Mannheim Gmbh | Neue Thiazolidindione und diese enthaltende Arzneimittel |
MX9603414A (es) | 1994-02-17 | 1997-03-29 | American Home Prod | Derivados de bifenilo sustituidos como inhibidores de fosfodiesterasa. |
US5691376A (en) | 1994-02-17 | 1997-11-25 | American Home Products Corporation | Substituted biphenyl derivatives |
JPH09136877A (ja) | 1995-06-16 | 1997-05-27 | Takeda Chem Ind Ltd | 複素環化合物、その製造法及び用途 |
AU701790B2 (en) | 1995-07-17 | 1999-02-04 | Centre International De Recherches Dermatologiques Galderma (C.I.R.D. Galderma) | Method for treating cancers using 6-{3-{1-adamantyl}- 4-hydroxyphenyl} |
JPH09176162A (ja) | 1995-12-22 | 1997-07-08 | Toubishi Yakuhin Kogyo Kk | チアゾリジンジオン誘導体及びその製造法並びにそれを含む医薬組成物 |
CN1196730A (zh) | 1996-06-19 | 1998-10-21 | 雷迪博士研究基金会 | 具有增强的抗糖尿病活性的穴糖酮的新的多晶型形式及其制备方法 |
JP2000515506A (ja) | 1996-07-08 | 2000-11-21 | ガルデルマ リサーチ アンド デヴェロップメント エス エヌ シー | アポプトーシスを誘発するアダマンチル誘導体及び該誘導体の抗癌剤としての使用 |
AU8747998A (en) | 1997-08-21 | 1999-03-16 | Takeda Chemical Industries Ltd. | Anti-inflammatory agent |
AU1052599A (en) | 1997-11-12 | 1999-05-31 | Institute Of Medicinal Molecular Design. Inc. | Retinoid receptor agonists |
US6262044B1 (en) | 1998-03-12 | 2001-07-17 | Novo Nordisk A/S | Modulators of protein tyrosine phosphatases (PTPASES) |
US6331633B1 (en) | 1998-05-08 | 2001-12-18 | Calyx Therapeutics Inc. | Heterocyclic analogs of diphenylethylene compounds |
WO2000010573A1 (fr) | 1998-08-21 | 2000-03-02 | Viropharma Incorporated | Composes, compositions et procedes pour traiter des infections virales et les maladies qui y sont liees |
AU6330999A (en) | 1998-09-30 | 2000-04-17 | Roche Diagnostics Gmbh | Rhodanine derivatives for the treatment and prevention of metabolic bone disorders |
AU3111700A (en) | 1998-12-04 | 2000-06-19 | Structural Bioinformatics Inc. | Methods and compositions for treating inflammatory diseases utilizing inhibitorsof tumor necrosis factor activity |
AU3958200A (en) | 1999-04-20 | 2000-11-02 | Novo Nordisk A/S | New compounds, their preparation and use |
US6462032B1 (en) | 1999-05-04 | 2002-10-08 | Wyeth | Cyclic regimens utilizing indoline derivatives |
HUP0203367A3 (en) | 1999-08-31 | 2004-12-28 | Maxia Pharmaceuticals Inc San | Benzylidine-thiazolidinediones and analogues and their use in the treatment of diabetes |
CN1159305C (zh) | 1999-11-12 | 2004-07-28 | 株式会社富吉摩托普拉泽兹 | 新的2-(n-氰基亚氨基)噻唑烷-4-酮衍生物 |
FR2812876B1 (fr) | 2000-08-08 | 2002-09-27 | Galderma Res & Dev | Nouveaux composes bi-aromatiques activateurs des recepteurs de type ppar-gamma et leur utilisation dans des compositions cosmetiques ou pharmaceutiques |
EP1385465A4 (fr) | 2001-03-07 | 2005-09-07 | Incyte San Diego Inc | Derives heterocycliques pour le traitement du cancer et d'autres maladies proliferatives |
EP1377559A4 (fr) | 2001-03-08 | 2005-09-28 | Incyte San Diego Inc | Molecules activant un recepteur rxr |
CA2438586A1 (fr) | 2001-03-14 | 2002-09-19 | Eli Lilly And Company | Modulateurs des recepteurs x de retinoides |
EP1392326B1 (fr) | 2001-04-04 | 2009-09-09 | Ortho-McNeil-Janssen Pharmaceuticals, Inc. | Polytherapie comprenant des inhibiteurs de reabsorption du glucose et des modulateurs du recepteur x du retinoide |
WO2003016267A1 (fr) | 2001-08-17 | 2003-02-27 | Incyte San Diego Incorporated | Derives d'oxime pour le traitement de la dyslipidemie et de l'hypercholesterolemie |
EP1456187A4 (fr) * | 2001-11-15 | 2005-02-09 | Incyte San Diego Inc | Heterocycles n-substitues pour le traitement de l'hypercholesterolemie, de la dyslipidemie et autres troubles du metabolisme, du cancer et de pathologies diverses |
AR037714A1 (es) | 2001-12-06 | 2004-12-01 | Maxia Pharmaceuticals Inc | Derivados de tiazolidinona y oxazolidinona 2-sustituidos para la inhibicion de fosfatasas y el tratamiento de cancer |
US7102000B2 (en) | 2002-03-08 | 2006-09-05 | Incyte San Diego Inc. | Heterocyclic amide derivatives for the treatment of diabetes and other diseases |
US7196108B2 (en) | 2002-03-08 | 2007-03-27 | Incyte San Diego Inc. | Bicyclic heterocycles for the treatment of diabetes and other diseases |
WO2004066952A2 (fr) | 2003-01-29 | 2004-08-12 | Incyte Corporation | Derives du benzoxazole, du benzothiazole et du benzimidazole destines a traiter le cancer et d'autres maladies |
ZA200509355B (en) | 2003-04-18 | 2007-03-28 | Incyte San Diego Inc | Substituted isochroman compounds for the treatment of metabolic disorders, cancer and other diseases |
-
2003
- 2003-03-06 US US10/384,352 patent/US7102000B2/en not_active Expired - Fee Related
- 2003-03-07 KR KR10-2004-7014099A patent/KR20050006126A/ko not_active Application Discontinuation
- 2003-03-07 IL IL16395203A patent/IL163952A0/xx unknown
- 2003-03-07 WO PCT/US2003/006784 patent/WO2003075924A1/fr active Application Filing
- 2003-03-07 ZA ZA200408057A patent/ZA200408057B/en unknown
- 2003-03-07 CA CA002478342A patent/CA2478342A1/fr not_active Abandoned
- 2003-03-07 JP JP2003574198A patent/JP2005530705A/ja active Pending
- 2003-03-07 RU RU2004129752/04A patent/RU2004129752A/ru not_active Application Discontinuation
- 2003-03-07 EP EP03744197A patent/EP1487443A4/fr not_active Withdrawn
- 2003-03-07 TW TW092105025A patent/TW200306184A/zh unknown
- 2003-03-07 MX MXPA04008733A patent/MXPA04008733A/es unknown
- 2003-03-07 CN CNA038101483A patent/CN1649586A/zh active Pending
- 2003-03-07 AU AU2003225682A patent/AU2003225682A1/en not_active Abandoned
-
2004
- 2004-10-07 NO NO20044250A patent/NO20044250L/no unknown
-
2006
- 2006-06-28 US US11/476,330 patent/US20060241138A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2478342A1 (fr) | 2003-09-18 |
RU2004129752A (ru) | 2005-05-10 |
CN1649586A (zh) | 2005-08-03 |
TW200306184A (en) | 2003-11-16 |
US20060241138A1 (en) | 2006-10-26 |
EP1487443A4 (fr) | 2006-04-12 |
AU2003225682A1 (en) | 2003-09-22 |
MXPA04008733A (es) | 2006-07-03 |
US7102000B2 (en) | 2006-09-05 |
EP1487443A1 (fr) | 2004-12-22 |
ZA200408057B (en) | 2007-05-30 |
AU2003225682A2 (en) | 2003-09-22 |
WO2003075924A1 (fr) | 2003-09-18 |
JP2005530705A (ja) | 2005-10-13 |
US20030216432A1 (en) | 2003-11-20 |
KR20050006126A (ko) | 2005-01-15 |
IL163952A0 (en) | 2005-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20044250L (no) | Heterocykliske amid-derivativer for behandling av diabetes og andre sykdommer | |
NO20052894D0 (no) | 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte | |
NO20055832D0 (no) | Fremstilling og anvendelse av arylalkylsyrederivater for behandling av fedme | |
DE60319865D1 (de) | Substituierte amin-derivate und deren verwendung zur behandlung von angionese-bedingten erkrankungen | |
NO20050570L (no) | Nye forbindelser, preparater og fremgangsmater for behandling av inflammasjonssykdommer og -tilstander | |
NO20050569D0 (no) | Fremgangsmate for behandling av alvorlig hjertesvikt og medikament for dette | |
NO20052796D0 (no) | Indolylpyrazinonderivater anvendelige for behandling av hyper-proliferative forstyrrelser og sykdommer assosiert med angiogenese | |
NO20055152D0 (no) | Karbonstyrilderivater og humor stabiliserende midler for behandling av humor forstyrrelser | |
NO20051493L (no) | Imidazolpyridiner og fremgangsmater for fremstilling og anvendelse av de samme | |
NO20042147L (no) | Heterocykliske forbindelser og fremgangsmater for anvendelse derav | |
DK1400518T3 (da) | Heterocycliske forbindelser og lægemidler | |
DK1673104T3 (da) | Fremføring af terapeutiske forbindelser til hjernen og andre væv | |
NO20053041D0 (no) | Behandling av diabetes. | |
NO20041216L (no) | Imidazol-4-karboksamidderivater, fremstilling og anvendelse derav for behandling av overvekt | |
DK1944322T3 (da) | Behandling af TNFalfa-relaterede sygdomme | |
PL376575A1 (pl) | Podstawione związki heterocykliczne oraz sposoby wykorzystania | |
HK1087103A1 (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
EA200500098A1 (ru) | Лекарственное средство и способ лечения патологического синдрома | |
IL179210A0 (en) | Heterocyclic derivatives for treatment of hyperlipidemia and related diseases | |
NO20053874L (no) | Formulering og metoder for behandling av thrombocytemi | |
NO20054535D0 (no) | Bifunksjonelle heterocykliske forbindelser og fremgangsmater for fremstilling og anvendelse av samme | |
AU2003279442A8 (en) | 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes | |
NO20045554L (no) | Fremgangsmate for behandling av diabetes | |
NO20041833L (no) | Heterocykliske forbindelser for anvendelse i behandlingen av forstyrrelser i urinveissystemet | |
NO20022600D0 (no) | Nye heterocykliske forbindelser og salter derav og medisinsk anvendelse av samme |